Coronary angioplasty in patients with previous bypass surgery  by Loop, Floyd D. & Whitlow, Patrick L.
1348
Editorial Comment
Coronary Angioplasty in Patients
With Previous Bypass Surgery*
FLOYD D . LOOP, MD, FACC,
PATRICK L. WHITLOW, MD, FACC
Cleveland, Ohio
The present study
. The timely article by Weintraub et al .
(1) in this issue of the Journal describes a high risk treatment
group that is seen with increasing frequency-patients with
previous coronary artery bypass surgery and progressive
native coronary disease and graft stenosis or graft failure
who are subsequently treated with angioplasty . In this
Emory University experience there was a 3.6% incidence
rate of emergency reoperation with a mortality rate of 6 .5%,
which is admirable under the conditions described. The first
lesson conveyed by this report is that all deaths and nonfatal
Q wave infarction occurred in patients who experienced
acute ischemia after failed angioplasty . In contrast, those
patients without ischemia benefited from surgery and are
assumed to have the same risk of an event as those under-
going elective reoperation .
The second lesson concerns the interval between proce-
dures. Because of more diffuse progressive disease, the
longer the interval between surgery and the next interven-
tion, in this case angioplasty, the greater the risk . For the
authors' patients (1) undergoing reoperation after failed
angioplasty <5 years after surgery, the early event rate was
22% compared with 39% when coronary angioplasty was
attempted a5 years after bypass surgery
. Vein graft athero-
sclerosis, progression of coronary disease and deterioration
of left ventricular performance increase over time . The
characteristics of this group of patients are further exempli-
fied in our series of 2,509 consecutive coronary reoperations
(2), in which one third of patents lost previously normal left
ventricular function in an average 8 year interval between
operations. Virtually all candidates for reoperation have
three vessel coronary disease, and in our reoperation series,
25% had severe left main artery narrowing .
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Selection of patients for coronary angioplasty among pa .
tients with previous coronary artery surgery . The avoidance
of ischemia and its deleterious effects begins with selection
of the patient. In addition to the pathoanatomic findings to be
noted, we believe that the following indications warrant the
risk of performing coronary angioplasty in patients who have
undergone bypass surgery : 1) recurrent angina affecting
life-style and uncontrolled by medication, and 2) a positive
exercise test associated with a high event rate (?2 mm ST
segment depression, low work load angina or low work load
ST segment depression, a decrease in systolic blood pres-
sure, or persistent ST depression lasting ?5 min before
recovery). After coronary artery surgery, four arteriographic
situations warrant consideration for angioplasty . Areas of
focal stenosis may be dilatable with the prospect for long-
term success I) in nonbypassed coronary arteries when
bypass grafts to other major vessels are fully patent, 2) at
distal anastomoses that are <3 years old, 3) in saphenous
vein grafts <3 years old, and 4) distal to an open graft
insertion point reachable through a fully patent nondiseased
graft .
Patients should be advised of different risks and our-
comes that depend on the age of their vein grafts . In our
series of 101 patients with angioplasty of saphenous vein
graft stenosis (3),
there was a high immediate success rate
but a real threat of distal embolization of atherosclerotic
material from angioplasty of vein grafts >36 months old . No
cardiac complications occurred in patients with early vein
graft stenosis . In our report (3), the recurrence rate of >50%
stenosis as assessed by ar:giography was 61% for 49 patients
who underwent cardiac catheterization after dilation of vein
graft lesions. Graft age affected the rate of recurrent steno-
sis ; the rate was 42% in grafts implanted <36 months before
angioplasty compared with 83% for grafts >36 months old.
The best results for angioplasty in this subset of patients
occur in those with early distal anastomotic stenosis ; the
worst result of conduit angioplasty occurs in vein grafts with
atherosclerotic involvement .
Some special situations must be considered individually .
Diffuse progressive disease ordinarily is an indication for
repeat bypass surgery, but there may be complications of
reoperation in patients with bilateral patent internal thoracic
artery grafts whose right thoracic artery crosses the midline.
Some patients may be cons!derd for angioplasty when there
is lack of suitable new graft material . Under these special
circumstances emergency reoperation is either hazardous or
not feasible .
Role of atherectomy. Atherectomy is an alternative to
angioplasty for atheromatous lesions in vein grafts . Early
reports (4) of directional atherectomy for vein graft stenosis
document a very high initial success rate and a 6 month
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recurrence rate of 30% (Multicenter Directional Atherec-
tomy Registry) ; however, distal embolization may still oc-
cur . Transluminal extraction atherectomy has been used
with high early success rates without distal cmbolization in
saphenous vein grafts (5), but the restenosis rate and residual
stenosis in grafts have not yet been reported . As new
mechanical devices evolve, the risk/benefit ratio for applica-
tion in patients with previous surgery will have to be
carefully assessed .
Recommendations to the angioplasty team. There are two
pleas that surgeons will make to cardiologists practicing
angioplasty : 1) communicate before performing coronary
dilation in a high risk patient, and 2) know when to stop .
Acute coronary occlusion can be made worse by repeated
attempts at dilation and valuable time may he wasted .
However, if the occlusion can be quickly traversed with a
guide wire, a perfusion catheter or coronary stem can
restore flow and stabilize ischemia. Development of technol-
ogy to decrease coronary ischemia during complicated an-
gioplasty or to stabilize an artery dissected by a balloon may
reduce ischemia and even lessen the need for emergency
reoperation in the future . Perfusion balloons (6), laser bal-
loons (7), coronary stents (g) and directional atherectomy (9)
all have potential for improving results after failed angio-
plasty .
If the patient has transient ischemia but is otherwise
hemodynamically stable, we believe that expedient transfer
to the operating room should be considered in lieu of
insertion of an intraaortic balloon pump . Balloon counter-
pulsation can easily be started in the operating room even
during anesthesia induction, and frequently, less ischemic
time elapses when attempts at balloon pump insertion are
not undertaken in the catheterization laboratory .
Surgical considerations. An unscheduled reoperation is
taxing for medical and technical personnel, and patients who
have unstable ischemia or infarction, or both, may cause
deviation from a routine technical plan . Many reports attest
to a lower incidence of arterial graft usage in emergency
surgery for angioplasty failure . Exigencies of time are
blamed: until now, speed was the main defense against
ischemia. Myocardial protection with cold cardioplegic so-
lution protects the nonischemic left ventricular segments,
but the region perfused by the acutely obstructed treatment
artery is poorly protected and will be subject to reperfusion
injury .
Reperfusion strategy : intraoperative controlled reperfu-
sion. Recently, warm aspartate-glutamate blood cardiople-
gia administered according to a controlled reperfusion pro-
tocol challenges the concept that rapid restoration of blood
supply is the critical objective in patients with ischemia (10) .
Experimental studies (lU have shown that cardiac ultra-
strue:ure and mitochondria) function are intact after >6 h of
ischemia . This reperfusion strategy consists of placing the
patient on total vented cardiopulmonary bypass ; warm sub-
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strata-enriched blood cardioplegia is delivered anterograde
into the aorta and retrograde through a coronary sinus
catheter. This anterograde-retrograde technique improves
distribution of cardioplegic reperfusate in regions supplied
by totally obstructed coronary arteries and is beneficial for
an occluded left anterior descending coronary artery (12) .
After the grafting is complete, a warm cardioplegic reperfu-
sate is administered for 20 min to the region revascularized
because of acute ischemia or infarction .
Controlled reperfosiorr is delivered over time . not by
volume, and its success depends on both the composition of
the reperfusate and decompression of the left ventricle . In
addition to documented recovery of regional wall function
up to I I h after acute coronary occlusion by Partington et at .
(12) as already described, Beyersdorf et al . (13) provide
confirmation in a clinical experience . These preliminary
reports show retur, of regional contractility to normal after
successful emergency revascularization for coronary angio-
plasly-related acute coronary occlusion . A protocol of mod-
ified blond cardioplegia may avoid transmural myocardial
infarction, whereas uncontrolled reperfusion consistently
resulted in depressed regional contractility . Inteaoperative
controlled reperfusion provides additional time to mobilize
one or both internal thoracic arteries . Use of arterial grafts
depends on the stability of the patient's condition at the time
of the emergency reoperation, but with improved myocardial
protection these arterial grafts should be used more fre-
quently, even for reoperation
.
Conclusions . The reader should be aware that this report
(I) of emergency revascularization from Emery University
represents the largest and best experience to date in one of
the most difficult to treat subsets of patients with coronary
atherosclerosis . Their results do not come easily and are
based on vast experience in selection, technique, anesthesia
and medical and surgical coordination. Their good results
may not be indicative of those obtained in the community at
large. The underlying message is that higher risk cases
require extensive communication between the cardiologist
and the patient and between the cardiologist and the surgeon
before reoperation .
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